Nguyen, D.-T.C.; Nader, C.; Bélanger, K.; Lapointe, S.; Lemieux, B.; Lemieux-Blanchard, É.; Bahary, J.-P.; Masucci, L.; Lambert, C.; Roberge, D.;
et al. A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas. Curr. Oncol. 2025, 32, 516.
https://doi.org/10.3390/curroncol32090516
AMA Style
Nguyen D-TC, Nader C, Bélanger K, Lapointe S, Lemieux B, Lemieux-Blanchard É, Bahary J-P, Masucci L, Lambert C, Roberge D,
et al. A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas. Current Oncology. 2025; 32(9):516.
https://doi.org/10.3390/curroncol32090516
Chicago/Turabian Style
Nguyen, Dan-Thanh Christine, Cyril Nader, Karl Bélanger, Sarah Lapointe, Bernard Lemieux, Émilie Lemieux-Blanchard, Jean-Paul Bahary, Laura Masucci, Carole Lambert, David Roberge,
and et al. 2025. "A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas" Current Oncology 32, no. 9: 516.
https://doi.org/10.3390/curroncol32090516
APA Style
Nguyen, D.-T. C., Nader, C., Bélanger, K., Lapointe, S., Lemieux, B., Lemieux-Blanchard, É., Bahary, J.-P., Masucci, L., Lambert, C., Roberge, D., Moumdjian, R., Labidi, M., Cayrol, R., & Florescu, M.
(2025). A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas. Current Oncology, 32(9), 516.
https://doi.org/10.3390/curroncol32090516
